Recursion Pharmaceuticals, Inc. remains a Sell as pipeline progress, notably REC-4881 in FAP, fails to surpass cheap alternatives like Celebrex. REC-4881's Phase 1/2 data show a median polyp reduction ...

Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...

Dec 8 (Reuters) - Recursion Pharma (RXRX.O), opens new tab, which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths ...

Shares of Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) are trading higher Monday after the pharmaceutical company reported positive data from an ongoing trial. What To Know: Recursion ...

Update: On Dec. 20, NYC-DSA's Electoral Working Group voted, 69% to 28%, to recommend endorsing Darializa Avila Chevalier's congressional campaign. The New York City chapter of the Democratic ...

V3.2, a family of open-source reasoning and agentic AI models. The high compute version, DeepSeek-V3.2-Speciale, performs ...

Are you a fan of high-quality audio but don't want to put anything in your ears? These are our favorite on-ear and over-ear headphones. I've been a contributing editor for PCMag since 2011. Before ...

Unfortunately you've used all of your gifts this month. Your counter will reset on the first day of next month.